Are Ocular and Ocular Adnexal Cancers Overdiagnosed? Historical Perspectives on Diagnosis

Welch H.G. , Black W.C. Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102(9): 605–613.

Kramer B.S. The science of early detection. Urol Oncol. 2004; 22(4): 344–347.

Bae J-M . Overdiagnosis: epidemiologic concept and estimation. Epidemiol Health. 2015; 37: e2015004.

Barry M.J. Screening for prostate cancer–the controversy that refuses to die. N Engl J Med. 2009; 360(13): 1351–1354.

Wegwarth O. , Gigerenzer G. Less or more: overdiagnosis and over-treatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med. 2013; 173(22): 2086–2087.

Heleno B. , Thomasen M.F. , Rodrigues D.S. Quantification of harms in cancer screening trials. literature review. BMJ. 2013: 347; f5334.

Welch H.G. , Gorski D.H. , Albertsen P.C. Trends in metastatic breast and prostate cancer – lessons in cancer dynamics. N Engl J Med. 2015; 373(18): 1685–1687.

Reese A.B. Precancerous melanosis and diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol. 1938; 19: 354–365.

Reese A.B. Precancerous melanosis and the results malignant melanoma (cancerous melanoma) of conjunctiva and skin of lids. Arch Ophthalmol. 1943; 29: 737–747.

Reese A.B. Precancerous and cancerous melanosis of the conjunctiva. Am J Ophthalmol. 1955; 39: 96–100.

Reese A.B. Tumors of the Eye. Hagerstown, MD: Harper & Row; 1977: 250–254.

Zimmerman L.E. Criteria for management of melanosis. Arch Ophthalmol. 1966; 76: 307–8.

Zimmerman L.E. The histogenesis of conjunctival melanomas: the first Algernon B. In: Jakobiec F.A. , ed. Ocular and Adnexal Tumors. Birmingham, AL: Aesculapius; 1977: 600–631.

Folberg R. , McLean I. , Zimmerman L.E. Primary acquired melanosis of the conjunctiva. Hum Pathol. 1985; 16(2): 129–135.

Folberg R. , McLean I.W. Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification and biologic behavior. Human Pathol. 1986; 17(7): 652–654.

Jakobiec F.A. , Silbert G. Are most iris “melanomas” really nevi? A clinicopathologic study of 189 lesions. Arch Ophthalmol. 1981; 99(12): 2117–2132.

Callender G.R. Malignant melanotic tumors of the eye: a study of histological types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol. 1931; 36: 131–141.

McLean I.W. , Zimmerman L.E. , Evans R.M. Reappraisal of Callender's spindle A type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol. 1978; 86(4): 557–564.

McLean I.W. Prognostic features of uveal melanoma. Ophthalmol Clin North Am. 1995; 8(1): 143–153.

McLean I.W. , Foster W.D. , Zimmerman L.E. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983; 96(4): 502–509.

Edge S. , Byrd D.R. , Compton C.C. , eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.

Yousef Y.A. , Finger P.T. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma. Arch Ophthalmol. 2012; 130(5): 599–606.

Shinder R. , Ivan D. , Seigler D. Feasibility of using American Joint Committee on Cancer Classification criteria for staging eyelid carcinomas. Orbit. 2011; 30(5): 202–207.

Sniegowski M.C. , Roberts D. , Bakhoum M. Ocular adnexal lymphoma: validation of American Joint Committee on Cancer seventh edition staging guidelines. Br J Ophthamol. 2014; 98(9): 1265–1260.

Graue G.F. , Finger P.T. , Maher E. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor. Eur J Ophthalmol. 2013; 23(3): 344–355.

Yousef Y.A. , Al-Hussaini M. , Mehyar M. Predictive value of TNM classification, international classification, and Reese-Ellsworth staging of retinoblastoma for the likelihood of high-risk pathologic features. Retina. 2015; 35(9): 1863–1869.

Kapatai G. , Brundler M.A. , Jenkinson H. Gene expression profiling identifies different sub-types of retinoblastoma. Br J Cancer. 2013; 109(2): 512–525.

Onken D.D. , Worley L.A. , Tuscan M.D. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn. 2010; 12(4): 461–468.